Jeppesen Radiation Oncology Center Bay City, MI - 48706

Jeppesen Radiation Oncology Center is categorized under Radiation Laboratories in Bay City, MI and active since 2010.

Jeppesen Radiation Oncology Center was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Radiation Laboratories business, which does work in the B2B market, and is classified as a Radiation Laboratories, under code number 541380 by the NAICS.

If you are seeking more information, feel free to contact Chris Cossin at the company’s single location by writing to 3180 East Midland Road, Bay City, Michigan MI 48706 or by phoning (989) 667-6670. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Jeppesen Radiation Oncology Center
Contact Person: Chris Cossin
Address: 3180 East Midland Road, Bay City, Michigan 48706
Phone Number: (989) 667-6670
Annual Revenue (USD): $500.000 to $999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Radiation Laboratories
SIC Code: 8734
NAICS Code: 541380
Share This Business:

Jeppesen Radiation Oncology Center was started in 2010 to provide professional Radiation Laboratories under the SIC code 8734 and NAICS code 541380. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Chris Cossin for inquiries that concern Jeppesen Radiation Oncology Center by calling the company number (989) 667-6670, as your correspondence is most welcome. Additionally, the physical location of the single location of Jeppesen Radiation Oncology Center can be found at the coordinates 43.602046,-83.926483 as well as the street address 3180 East Midland Road in Bay City, Michigan 48706.

For its online presence, you may visit Jeppesen Radiation Oncology Center’s website at and engage with its social media outlets through on Twitter and on Facebook.